Swartz L - Search Results

1

Socio-behaviour challenges to phase III HIV vaccine trials in Sub-Saharan Africa.

Smit J, Middelkoop K, Myer L, Lindegger G, Swartz L, Seedat S, Tucker T, Wood R, Bekker LG, Stein DJ. Smit J, et al. Among authors: swartz l. Afr Health Sci. 2005 Sep;5(3):198-206. doi: 10.5555/afhs.2005.5.3.198. Afr Health Sci. 2005. PMID: 16245989 Free PMC article. Review.

2

Social and behavioral aspects of child and adolescent participation in HIV vaccine trials.

Swartz L, Kagee A, Kafaar Z, Smit J, Bhana A, Gray G, Lesch A, Lindegger G, Milford C, Richter L, Seedat S, Skhosana N, Stein DJ. Swartz L, et al. J Int Assoc Physicians AIDS Care (Chic). 2005 Dec;4(4):89-92. doi: 10.1177/1545109705285033. J Int Assoc Physicians AIDS Care (Chic). 2005. PMID: 16533797

3

Community participation in AIDS vaccine trials: empowerment or science?

Swartz L, Kagee A. Swartz L, et al. Soc Sci Med. 2006 Sep;63(5):1143-6. doi: 10.1016/j.socscimed.2006.03.032. Epub 2006 May 16. Soc Sci Med. 2006. PMID: 16707200

4

Ethical and social dilemmas in community-based controlled trials in situations of poverty: a view from a South African project.

Nama N, Swartz L. Nama N, et al. Among authors: swartz l. J Community Appl Soc Psychol. 2002 Jul-Aug;12(4):286-97. doi: 10.1002/casp.682. J Community Appl Soc Psychol. 2002. PMID: 16881161

5

Manifestations of affective disturbance in sub-Saharan Africa: key themes.

Tomlinson M, Swartz L, Kruger LM, Gureje O. Tomlinson M, et al. Among authors: swartz l. J Affect Disord. 2007 Sep;102(1-3):191-8. doi: 10.1016/j.jad.2006.09.029. Epub 2006 Nov 27. J Affect Disord. 2007. PMID: 17126409 Review.

6

Paediatric HIV/AIDS disclosure: towards a developmental and process-oriented approach.

Lesch A, Swartz L, Kagee A, Moodley K, Kafaar Z, Myer L, Cotton M. Lesch A, et al. Among authors: swartz l. AIDS Care. 2007 Jul;19(6):811-6. doi: 10.1080/09540120601129301. AIDS Care. 2007. PMID: 17573602 Review.

7

Predicting hypothetical willingness to participate (WTP) in a future phase III HIV vaccine trial among high-risk adolescents.

Giocos G, Kagee A, Swartz L. Giocos G, et al. Among authors: swartz l. AIDS Behav. 2008 Nov;12(6):842-51. doi: 10.1007/s10461-007-9289-5. Epub 2007 Aug 1. AIDS Behav. 2008. PMID: 17668313

8

Is participation in HIV vaccine trials a health promoting behaviour?

Kafaar Z, Kagee A, Lesch A, Swartz L. Kafaar Z, et al. Among authors: swartz l. AIDS Care. 2007 Nov;19(10):1307-9. doi: 10.1080/09540120701408126. AIDS Care. 2007. PMID: 18071976

9

Inhibitors and facilitators of willingness to participate (WTP) in an HIV vaccine trial: construction and initial validation of the Inhibitors and Facilitators of Willingness to Participate Scale (WPS) among women at risk for HIV infection.

Fincham D, Kagee A, Swartz L. Fincham D, et al. Among authors: swartz l. AIDS Care. 2010 Apr;22(4):452-61. doi: 10.1080/09540120903202939. AIDS Care. 2010. PMID: 20146113

10

Broadening psychology's contribution to addressing issues of HIV/AIDS, poverty and nutrition: structural issues as constraints and opportunities.

Tomlinson M, Rohleder P, Swartz L, Drimie S, Kagee A. Tomlinson M, et al. Among authors: swartz l. J Health Psychol. 2010 Oct;15(7):972-81. doi: 10.1177/1359105310371399. Epub 2010 Jul 14. J Health Psychol. 2010. PMID: 20631038

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

329 results

Search Page

Filters